Taken together, these data reinforce the biological plausibility that disruption of MRAP2-mediated GPCR signaling contributes to obesity and related metabolic disturbances, but the current functional evidence is incomplete and should be regarded as hypothesis-generating. The gene discussed is MRAP2; the disease is Obesity.